In a new study, researchers found that when a woman receives the vaccine in the first year of pregnancy, she’s less likely to get a repeat infection.
The study, published in The Lancet Infectious Diseases, also found that women who received the vaccine early in their pregnancies had significantly lower rates of new HPV infections in the years that followed.
But women who didn’t receive the vaccine until after birth had higher rates of reinfections.
“The vaccine protects against HPV infection and it protects against infection from other types of infections that are associated with high rates of HPV infection,” said Dr. Nafeez Ahmed, the lead author of the study.
“We were able to demonstrate that even in women who had been vaccinated, their cervical cancer recurrence rates were not related to their HPV vaccination status.
This is a very important finding, because if HPV vaccination was not effective in preventing recurrence of cervical cancer, we would expect to see similar findings for HPV vaccine efficacy.”
These are important findings because they highlight the importance of HPV vaccine uptake for cervical cancer control, and the importance for cervical health care providers in vaccinating their patients for HPV vaccination,” he added.
According to Dr. Ahmed, HPV vaccines have been shown to protect against the types of infection that cause most cervical cancers, including HPV-16 and HPV-18.”
We were also able to show, however, that if women received the HPV vaccine as late as they were at the time of their first cervical cancer screening, they were still at higher risk of having an HPV infection.””
In our study, we were able also to show that if the vaccine was given at a later age, the vaccine protects from these infections.
We were also able to show, however, that if women received the HPV vaccine as late as they were at the time of their first cervical cancer screening, they were still at higher risk of having an HPV infection.”
This is important because it shows that the vaccine is not only protective against infection, but it is also protective against reinfection, which is a higher risk for a woman who is not vaccinated.